nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0453	0.0591	CbGbCtD
Pioglitazone—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.044	0.0574	CbGbCtD
Pioglitazone—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0398	0.0519	CbGbCtD
Pioglitazone—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0398	0.0519	CbGbCtD
Pioglitazone—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0222	0.029	CbGbCtD
Pioglitazone—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0222	0.029	CbGbCtD
Pioglitazone—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0219	0.0286	CbGbCtD
Pioglitazone—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0206	0.0269	CbGbCtD
Pioglitazone—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0186	0.0243	CbGbCtD
Pioglitazone—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0186	0.0243	CbGbCtD
Pioglitazone—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0182	0.0238	CbGbCtD
Pioglitazone—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0171	0.0223	CbGbCtD
Pioglitazone—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0171	0.0223	CbGbCtD
Pioglitazone—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0168	0.022	CbGbCtD
Pioglitazone—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0168	0.022	CbGbCtD
Pioglitazone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0167	0.0217	CbGbCtD
Pioglitazone—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0161	0.021	CbGbCtD
Pioglitazone—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0161	0.021	CbGbCtD
Pioglitazone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0157	0.0204	CbGbCtD
Pioglitazone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0157	0.0204	CbGbCtD
Pioglitazone—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0156	0.0204	CbGbCtD
Pioglitazone—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0155	0.0202	CbGbCtD
Pioglitazone—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0155	0.0202	CbGbCtD
Pioglitazone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0142	0.0185	CbGbCtD
Pioglitazone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0142	0.0185	CbGbCtD
Pioglitazone—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0141	0.0184	CbGbCtD
Pioglitazone—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0141	0.0184	CbGbCtD
Pioglitazone—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0135	0.0177	CbGbCtD
Pioglitazone—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0134	0.0174	CbGbCtD
Pioglitazone—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.013	0.0169	CbGbCtD
Pioglitazone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0122	0.0159	CbGbCtD
Pioglitazone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0119	0.0155	CbGbCtD
Pioglitazone—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.0153	CbGbCtD
Pioglitazone—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0153	CbGbCtD
Pioglitazone—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0113	0.0147	CbGbCtD
Pioglitazone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0107	0.014	CbGbCtD
Pioglitazone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0107	0.014	CbGbCtD
Pioglitazone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0106	0.0138	CbGbCtD
Pioglitazone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00996	0.013	CbGbCtD
Pioglitazone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00996	0.013	CbGbCtD
Pioglitazone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00901	0.0117	CbGbCtD
Pioglitazone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00901	0.0117	CbGbCtD
Pioglitazone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00778	0.0101	CbGbCtD
Pioglitazone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00755	0.00984	CbGbCtD
Pioglitazone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00683	0.0089	CbGbCtD
Pioglitazone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00683	0.0089	CbGbCtD
Pioglitazone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00654	0.00854	CbGbCtD
Pioglitazone—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00222	0.0641	CbGeAlD
Pioglitazone—PPARG—endothelium—acquired immunodeficiency syndrome	0.00216	0.0623	CbGeAlD
Pioglitazone—PPARG—blood plasma—acquired immunodeficiency syndrome	0.00192	0.0553	CbGeAlD
Pioglitazone—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00145	0.0418	CbGeAlD
Pioglitazone—SLCO1B3—vagina—acquired immunodeficiency syndrome	0.00131	0.0376	CbGeAlD
Pioglitazone—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00126	0.0365	CbGeAlD
Pioglitazone—SLCO1B3—lung—acquired immunodeficiency syndrome	0.00124	0.0356	CbGeAlD
Pioglitazone—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00115	0.0333	CbGeAlD
Pioglitazone—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0324	CbGeAlD
Pioglitazone—Rosiglitazone—ALB—acquired immunodeficiency syndrome	0.00106	1	CrCbGaD
Pioglitazone—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00103	0.0296	CbGeAlD
Pioglitazone—PPARG—skin of body—acquired immunodeficiency syndrome	0.000922	0.0266	CbGeAlD
Pioglitazone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000857	0.0247	CbGeAlD
Pioglitazone—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000855	0.0247	CbGeAlD
Pioglitazone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000843	0.0243	CbGeAlD
Pioglitazone—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000815	0.0235	CbGeAlD
Pioglitazone—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.000747	0.0215	CbGeAlD
Pioglitazone—PPARG—digestive system—acquired immunodeficiency syndrome	0.000738	0.0213	CbGeAlD
Pioglitazone—PPARG—blood—acquired immunodeficiency syndrome	0.000703	0.0203	CbGeAlD
Pioglitazone—PPARG—bone marrow—acquired immunodeficiency syndrome	0.00068	0.0196	CbGeAlD
Pioglitazone—PPARG—vagina—acquired immunodeficiency syndrome	0.000651	0.0188	CbGeAlD
Pioglitazone—PPARG—lung—acquired immunodeficiency syndrome	0.000616	0.0178	CbGeAlD
Pioglitazone—PPARG—nervous system—acquired immunodeficiency syndrome	0.000571	0.0164	CbGeAlD
Pioglitazone—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000557	0.0161	CbGeAlD
Pioglitazone—PPARG—central nervous system—acquired immunodeficiency syndrome	0.000549	0.0158	CbGeAlD
Pioglitazone—CYP2C19—blood—acquired immunodeficiency syndrome	0.000531	0.0153	CbGeAlD
Pioglitazone—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000493	0.0142	CbGeAlD
Pioglitazone—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000492	0.0142	CbGeAlD
Pioglitazone—CYP2C8—blood—acquired immunodeficiency syndrome	0.000463	0.0134	CbGeAlD
Pioglitazone—PPARG—brain—acquired immunodeficiency syndrome	0.000436	0.0126	CbGeAlD
Pioglitazone—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000432	0.0125	CbGeAlD
Pioglitazone—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000429	0.0124	CbGeAlD
Pioglitazone—PPARG—lymph node—acquired immunodeficiency syndrome	0.000421	0.0121	CbGeAlD
Pioglitazone—CYP2C9—blood—acquired immunodeficiency syndrome	0.000412	0.0119	CbGeAlD
Pioglitazone—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000394	0.0114	CbGeAlD
Pioglitazone—PTGS1—blood—acquired immunodeficiency syndrome	0.000376	0.0108	CbGeAlD
Pioglitazone—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000362	0.0104	CbGeAlD
Pioglitazone—PTGS1—vagina—acquired immunodeficiency syndrome	0.000348	0.01	CbGeAlD
Pioglitazone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000329	0.00949	CbGeAlD
Pioglitazone—PTGS1—lung—acquired immunodeficiency syndrome	0.000329	0.00949	CbGeAlD
Pioglitazone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000324	0.00934	CbGeAlD
Pioglitazone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000314	0.00905	CbGeAlD
Pioglitazone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000309	0.0089	CbGeAlD
Pioglitazone—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000305	0.00879	CbGeAlD
Pioglitazone—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000294	0.00846	CbGeAlD
Pioglitazone—CYP2C8—brain—acquired immunodeficiency syndrome	0.000288	0.00829	CbGeAlD
Pioglitazone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000255	0.00734	CbGeAlD
Pioglitazone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000251	0.00723	CbGeAlD
Pioglitazone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000245	0.00707	CbGeAlD
Pioglitazone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000241	0.00696	CbGeAlD
Pioglitazone—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00121	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Pioglitazone—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.0012	CcSEcCtD
Pioglitazone—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Pioglitazone—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Pioglitazone—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Pioglitazone—Malaise—Indinavir—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Pioglitazone—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000237	0.0012	CcSEcCtD
Pioglitazone—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000236	0.00119	CcSEcCtD
Pioglitazone—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000236	0.00119	CcSEcCtD
Pioglitazone—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.00119	CcSEcCtD
Pioglitazone—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Pioglitazone—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Pioglitazone—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00118	CcSEcCtD
Pioglitazone—PTGS1—brain—acquired immunodeficiency syndrome	0.000233	0.00672	CbGeAlD
Pioglitazone—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000233	0.00118	CcSEcCtD
Pioglitazone—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00117	CcSEcCtD
Pioglitazone—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00117	CcSEcCtD
Pioglitazone—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.00117	CcSEcCtD
Pioglitazone—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00117	CcSEcCtD
Pioglitazone—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.00116	CcSEcCtD
Pioglitazone—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00116	CcSEcCtD
Pioglitazone—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.00116	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000229	0.00116	CcSEcCtD
Pioglitazone—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000229	0.00116	CcSEcCtD
Pioglitazone—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000229	0.00116	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000229	0.00116	CcSEcCtD
Pioglitazone—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000228	0.00116	CcSEcCtD
Pioglitazone—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Pioglitazone—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00115	CcSEcCtD
Pioglitazone—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00115	CcSEcCtD
Pioglitazone—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.00115	CcSEcCtD
Pioglitazone—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.00115	CcSEcCtD
Pioglitazone—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.00115	CcSEcCtD
Pioglitazone—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000226	0.00114	CcSEcCtD
Pioglitazone—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000226	0.00114	CcSEcCtD
Pioglitazone—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000225	0.00649	CbGeAlD
Pioglitazone—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000225	0.00114	CcSEcCtD
Pioglitazone—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.00114	CcSEcCtD
Pioglitazone—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000225	0.00114	CcSEcCtD
Pioglitazone—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000225	0.00114	CcSEcCtD
Pioglitazone—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.00113	CcSEcCtD
Pioglitazone—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.00113	CcSEcCtD
Pioglitazone—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00113	CcSEcCtD
Pioglitazone—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00113	CcSEcCtD
Pioglitazone—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00113	CcSEcCtD
Pioglitazone—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00113	CcSEcCtD
Pioglitazone—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000223	0.00113	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000222	0.00112	CcSEcCtD
Pioglitazone—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000221	0.00112	CcSEcCtD
Pioglitazone—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00111	CcSEcCtD
Pioglitazone—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Pioglitazone—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Pioglitazone—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Pioglitazone—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Pioglitazone—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Pioglitazone—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.00111	CcSEcCtD
Pioglitazone—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.0011	CcSEcCtD
Pioglitazone—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.0011	CcSEcCtD
Pioglitazone—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.00109	CcSEcCtD
Pioglitazone—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000215	0.00109	CcSEcCtD
Pioglitazone—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Pioglitazone—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Pioglitazone—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Pioglitazone—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.00108	CcSEcCtD
Pioglitazone—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00108	CcSEcCtD
Pioglitazone—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00107	CcSEcCtD
Pioglitazone—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.00107	CcSEcCtD
Pioglitazone—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000211	0.00107	CcSEcCtD
Pioglitazone—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00107	CcSEcCtD
Pioglitazone—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00107	CcSEcCtD
Pioglitazone—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00107	CcSEcCtD
Pioglitazone—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00107	CcSEcCtD
Pioglitazone—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00021	0.00107	CcSEcCtD
Pioglitazone—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Pioglitazone—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.00106	CcSEcCtD
Pioglitazone—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.00106	CcSEcCtD
Pioglitazone—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000209	0.00106	CcSEcCtD
Pioglitazone—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.00106	CcSEcCtD
Pioglitazone—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00106	CcSEcCtD
Pioglitazone—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000208	0.00105	CcSEcCtD
Pioglitazone—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00105	CcSEcCtD
Pioglitazone—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000208	0.00105	CcSEcCtD
Pioglitazone—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000207	0.00105	CcSEcCtD
Pioglitazone—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000207	0.00105	CcSEcCtD
Pioglitazone—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000205	0.00104	CcSEcCtD
Pioglitazone—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.00104	CcSEcCtD
Pioglitazone—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00103	CcSEcCtD
Pioglitazone—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00103	CcSEcCtD
Pioglitazone—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00103	CcSEcCtD
Pioglitazone—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00103	CcSEcCtD
Pioglitazone—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000202	0.00102	CcSEcCtD
Pioglitazone—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.00102	CcSEcCtD
Pioglitazone—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.00102	CcSEcCtD
Pioglitazone—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.00102	CcSEcCtD
Pioglitazone—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.00102	CcSEcCtD
Pioglitazone—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.00101	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000199	0.00101	CcSEcCtD
Pioglitazone—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000198	0.001	CcSEcCtD
Pioglitazone—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.001	CcSEcCtD
Pioglitazone—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.001	CcSEcCtD
Pioglitazone—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.001	CcSEcCtD
Pioglitazone—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000998	CcSEcCtD
Pioglitazone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000197	0.000996	CcSEcCtD
Pioglitazone—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000995	CcSEcCtD
Pioglitazone—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000992	CcSEcCtD
Pioglitazone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000196	0.000991	CcSEcCtD
Pioglitazone—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.00099	CcSEcCtD
Pioglitazone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000195	0.000988	CcSEcCtD
Pioglitazone—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000988	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000988	CcSEcCtD
Pioglitazone—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.000986	CcSEcCtD
Pioglitazone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000194	0.00098	CcSEcCtD
Pioglitazone—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00098	CcSEcCtD
Pioglitazone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.00098	CcSEcCtD
Pioglitazone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000973	CcSEcCtD
Pioglitazone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000192	0.000973	CcSEcCtD
Pioglitazone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000192	0.00552	CbGeAlD
Pioglitazone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000191	0.000968	CcSEcCtD
Pioglitazone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000191	0.000966	CcSEcCtD
Pioglitazone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000191	0.000965	CcSEcCtD
Pioglitazone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000964	CcSEcCtD
Pioglitazone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00019	0.000962	CcSEcCtD
Pioglitazone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.00096	CcSEcCtD
Pioglitazone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00096	CcSEcCtD
Pioglitazone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000959	CcSEcCtD
Pioglitazone—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000952	CcSEcCtD
Pioglitazone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000188	0.00095	CcSEcCtD
Pioglitazone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000187	0.000948	CcSEcCtD
Pioglitazone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000947	CcSEcCtD
Pioglitazone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000946	CcSEcCtD
Pioglitazone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000945	CcSEcCtD
Pioglitazone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000945	CcSEcCtD
Pioglitazone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000945	CcSEcCtD
Pioglitazone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000942	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000939	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000185	0.000936	CcSEcCtD
Pioglitazone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000185	0.000935	CcSEcCtD
Pioglitazone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000934	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000933	CcSEcCtD
Pioglitazone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000932	CcSEcCtD
Pioglitazone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.000926	CcSEcCtD
Pioglitazone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000926	CcSEcCtD
Pioglitazone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000923	CcSEcCtD
Pioglitazone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000182	0.00092	CcSEcCtD
Pioglitazone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000919	CcSEcCtD
Pioglitazone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000181	0.000917	CcSEcCtD
Pioglitazone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000916	CcSEcCtD
Pioglitazone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000913	CcSEcCtD
Pioglitazone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00091	CcSEcCtD
Pioglitazone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00091	CcSEcCtD
Pioglitazone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00091	CcSEcCtD
Pioglitazone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000906	CcSEcCtD
Pioglitazone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000179	0.000904	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000904	CcSEcCtD
Pioglitazone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000899	CcSEcCtD
Pioglitazone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000893	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000893	CcSEcCtD
Pioglitazone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000176	0.000889	CcSEcCtD
Pioglitazone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000889	CcSEcCtD
Pioglitazone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000175	0.000887	CcSEcCtD
Pioglitazone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000886	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.000884	CcSEcCtD
Pioglitazone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.000883	CcSEcCtD
Pioglitazone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00088	CcSEcCtD
Pioglitazone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000876	CcSEcCtD
Pioglitazone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000874	CcSEcCtD
Pioglitazone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000173	0.000874	CcSEcCtD
Pioglitazone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000872	CcSEcCtD
Pioglitazone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000172	0.00087	CcSEcCtD
Pioglitazone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000868	CcSEcCtD
Pioglitazone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000868	CcSEcCtD
Pioglitazone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000868	CcSEcCtD
Pioglitazone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000866	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000862	CcSEcCtD
Pioglitazone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00017	0.000861	CcSEcCtD
Pioglitazone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000858	CcSEcCtD
Pioglitazone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000855	CcSEcCtD
Pioglitazone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000847	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000846	CcSEcCtD
Pioglitazone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000845	CcSEcCtD
Pioglitazone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000844	CcSEcCtD
Pioglitazone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000843	CcSEcCtD
Pioglitazone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000166	0.000843	CcSEcCtD
Pioglitazone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000166	0.00084	CcSEcCtD
Pioglitazone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.000836	CcSEcCtD
Pioglitazone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000832	CcSEcCtD
Pioglitazone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000832	CcSEcCtD
Pioglitazone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000163	0.000828	CcSEcCtD
Pioglitazone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000827	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000826	CcSEcCtD
Pioglitazone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.00082	CcSEcCtD
Pioglitazone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000816	CcSEcCtD
Pioglitazone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000814	CcSEcCtD
Pioglitazone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000808	CcSEcCtD
Pioglitazone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000808	CcSEcCtD
Pioglitazone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000807	CcSEcCtD
Pioglitazone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000804	CcSEcCtD
Pioglitazone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000158	0.000799	CcSEcCtD
Pioglitazone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.000797	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000795	CcSEcCtD
Pioglitazone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000789	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000782	CcSEcCtD
Pioglitazone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000781	CcSEcCtD
Pioglitazone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000778	CcSEcCtD
Pioglitazone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000778	CcSEcCtD
Pioglitazone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000778	CcSEcCtD
Pioglitazone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.000771	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000758	CcSEcCtD
Pioglitazone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000755	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000753	CcSEcCtD
Pioglitazone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000753	CcSEcCtD
Pioglitazone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000752	CcSEcCtD
Pioglitazone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000747	CcSEcCtD
Pioglitazone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000742	CcSEcCtD
Pioglitazone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000742	CcSEcCtD
Pioglitazone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000735	CcSEcCtD
Pioglitazone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.00073	CcSEcCtD
Pioglitazone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000722	CcSEcCtD
Pioglitazone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00072	CcSEcCtD
Pioglitazone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000719	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000718	CcSEcCtD
Pioglitazone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000717	CcSEcCtD
Pioglitazone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000717	CcSEcCtD
Pioglitazone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000703	CcSEcCtD
Pioglitazone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000701	CcSEcCtD
Pioglitazone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000693	CcSEcCtD
Pioglitazone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000686	CcSEcCtD
Pioglitazone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000679	CcSEcCtD
Pioglitazone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000677	CcSEcCtD
Pioglitazone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.00067	CcSEcCtD
Pioglitazone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000668	CcSEcCtD
Pioglitazone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000661	CcSEcCtD
Pioglitazone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.00065	CcSEcCtD
Pioglitazone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000648	CcSEcCtD
Pioglitazone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000643	CcSEcCtD
Pioglitazone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000642	CcSEcCtD
Pioglitazone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000626	CcSEcCtD
Pioglitazone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.00062	CcSEcCtD
Pioglitazone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000614	CcSEcCtD
Pioglitazone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000613	CcSEcCtD
Pioglitazone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000599	CcSEcCtD
Pioglitazone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000597	CcSEcCtD
Pioglitazone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000597	CcSEcCtD
Pioglitazone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000577	CcSEcCtD
Pioglitazone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000569	CcSEcCtD
Pioglitazone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000568	CcSEcCtD
Pioglitazone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00055	CcSEcCtD
Pioglitazone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000546	CcSEcCtD
Pioglitazone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000521	CcSEcCtD
